AJCN EB Program 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow An erratum has been published
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wortsman, J.
Right arrow Articles by Holick, M. F
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wortsman, J.
Right arrow Articles by Holick, M. F
Agricola
Right arrow Articles by Wortsman, J.
Right arrow Articles by Holick, M. F
American Journal of Clinical Nutrition, Vol. 72, No. 3, 690-693, September 2000
© 2000 American Society for Clinical Nutrition


Original Research Communications

Decreased bioavailability of vitamin D in obesity1,2,3

Jacobo Wortsman, Lois Y Matsuoka, Tai C Chen, Zhiren Lu and Michael F Holick

1 From the Southern Illinois University School of Medicine, Springfield; Jefferson Medical College, Philadelphia; and the Boston University Medical Center.

2 Supported by grant nos. MO1RR 00533 and AR 369637 from the National Institutes of Health.

3 Reprints not available. Address correspondence to MF Holick, Boston University School of Medicine, 715 Albany Street, M1013, Boston, MA 02118. E-mail: mfholick{at}bu.edu.


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 SUBJECTS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Background: Obesity is associated with vitamin D insufficiency and secondary hyperparathyroidism.

Objective: This study assessed whether obesity alters the cutaneous production of vitamin D3 (cholecalciferol) or the intestinal absorption of vitamin D2 (ergocalciferol).

Design: Healthy, white, obese [body mass index (BMI; in kg/m2) >= 30] and matched lean control subjects (BMI <= 25) received either whole-body ultraviolet radiation or a pharmacologic dose of vitamin D2 orally.

Results: Obese subjects had significantly lower basal 25-hydroxyvitamin D concentrations and higher parathyroid hormone concentrations than did age-matched control subjects. Evaluation of blood vitamin D3 concentrations 24 h after whole-body irradiation showed that the incremental increase in vitamin D3 was 57% lower in obese than in nonobese subjects. The content of the vitamin D3 precursor 7-dehydrocholesterol in the skin of obese and nonobese subjects did not differ significantly between groups nor did its conversion to previtamin D3 after irradiation in vitro. The obese and nonobese subjects received an oral dose of 50000 IU (1.25 mg) vitamin D2. BMI was inversely correlated with serum vitamin D3 concentrations after irradiation (r = -0.55, P = 0.003) and with peak serum vitamin D2 concentrations after vitamin D2 intake (r = -0.56, P = 0.007).

Conclusions: Obesity-associated vitamin D insufficiency is likely due to the decreased bioavailability of vitamin D3 from cutaneous and dietary sources because of its deposition in body fat compartments.

Key Words: Vitamin D • ultraviolet radiation • tanning bed • obesity • 25-hydroxyvitamin D • parathyroid hormone • obesity • vitamin D3 • sunlight • obesity • 25-hydroxyvitamin D3 • bioavailability


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 SUBJECTS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Obese individuals, as a group, have low plasma concentrations of 25-hydroxyvitamin D [25(OH)D] (15), which are associated with increased plasma concentrations of immunoreactive parathyroid hormone (1, 6, 7). Although the explanation for the increased risk of vitamin D deficiency in obesity is unknown, it has been postulated that obese individuals may avoid exposure to solar ultraviolet (UV) radiation, which is indispensable for the cutaneous synthesis of vitamin D3 (3). Alternatively, it has been proposed that production of the active vitamin D metabolite 1,25-dihydroxyvitamin D [1,25(OH)2D] is enhanced and thus, its higher concentrations exert negative feedback control on the hepatic synthesis of 25(OH)D (1). It has also been suggested that the metabolic clearance of vitamin D may increase in obesity, possibly with enhanced uptake by adipose tissue (2).

Clarification of the mechanism for the subnormal concentrations of 25(OH)D in obesity is nevertheless relevant for the management of this highly prevalent condition. If, for example, the increased risk of vitamin D deficiency were the expression of a lack of exposure to sunlight, it would perhaps be only of academic interest. Conversely, if the increased risk of vitamin D deficiency in obesity were the result of a primary alteration or a direct consequence of obesity itself then a rational intervention could be instituted. We therefore performed dynamic testing to evaluate the blood concentrations of vitamin D in obese and nonobese subjects in response to UV-B irradiation or an oral dose of vitamin D2. We also performed studies in vitro to determine whether obesity affects the cutaneous production of vitamin D3.


    SUBJECTS AND METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 SUBJECTS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Subjects
The experimental population was 19 healthy whites (skin types II and III) of normal body weight [body mass index (BMI; in kg/m2) <= 25] and 19 healthy, obese subjects (skin types II and III; BMI > 30). Subjects were recruited among medical school personnel and had similar socioeconomic status. None of the subjects had a history of hepatic or renal disorders and none were taking vitamin D supplements, anticonvulsant medications, or corticosteroids. The study was performed during the winter (November through February) and the subjects refrained from sunlight exposure beginning 24 h before the study and during the study. All subjects gave their informed consent and the study was approved by the Jefferson Medical College (Philadelphia) Institutional Review Board.

Methods
The study of cutaneous vitamin D3 synthesis in response to UV-B irradiation consisted of submitting the subjects to whole-body irradiation in a phototherapy unit that emits wavelengths of 260–330 nm as described previously (8). The radiation delivered at these wavelengths was 0.2 mW/cm2, determined at a distance of 30 cm from the source. A single, 27-mJ/cm2 suberythemic dose of UV-B (290–320 nm) was delivered (one minimal erythema dose: 33–36 mJ/cm2). Because peak serum vitamin D3 concentrations occur 24 h after acute UV-B radiation exposure (9), blood samples were obtained 1 h before (basal determination) and 24 h after UV-B radiation exposure. Changes in serum vitamin D3 concentrations over this period reflected the synthesis and transport of vitamin D3 from the skin into the bloodstream (10).

The study of the response to an oral challenge with vitamin D2 was performed >=1 mo after the study of cutaneous vitamin D3 photosynthesis. The oral vitamin D2 loading test consisted of a modification of the vitamin D absorption test described previously by Lo et al (11). Subjects were instructed to avoid dairy products for 1 wk before the study and to fast from 2000 the night before the test. A basal blood sample was obtained at 0800, and immediately thereafter the subjects ingested a capsule of vitamin D2 [50000 IU (1.25 mg) ergocalciferol] with 120 mL water. Subjects were allowed to eat 1 h later. Follow-up blood samples were obtained 6, 10, and 24 h after the intake of vitamin D2. Serum was separated promptly and stored at -20°C until analyzed.

The serum assays for vitamin D2 and vitamin D3 were performed by HPLC (12). The intraassay and interassay variations for this assay were 10% and 13%, respectively. The serum assays for 25(OH)D and 1,25(OH)2D were performed by using binding-protein assays as described previously (13, 14). The intraassay and interassay variations for the 25(OH)D and 1,25(OH)2D assays were 8% and 10% and 10% and 12%, respectively. Parathyroid hormone concentrations (midmolecule assay; Star Corp Inc, Stillwater, MN) were measured at the Medical University of South Carolina, Charleston.

A total of 13 control (age: 34 ± 3 y; BMI: 22.2 ± 0.04) and 13 obese (age: 37 ± 2 y; BMI: 38 ± 1.7) individuals participated in the study of the cutaneous synthesis of vitamin D3 in response to UV-B irradiation and 11 control (age: 36 ± 4 y; BMI: 21.4 ± 0.6) and 11 obese (age: 39 ± 3 y; BMI: 35.7 ± 1.8) subjects participated in the oral vitamin D2 loading test. There was some overlap among the experimental subjects; 5 nonobese and 7 obese subjects participated in both studies. Nevertheless, characteristics of the population included in each study were similar.

In vitro studies
The direct effect of obesity on the synthetic capacity of the skin to produce vitamin D3 was studied in whole skin (epidermis and dermis) obtained during surgery from 2 obese subjects (age: 27 and 84 y) and 2 nonobese subjects (age: 42 and 73 y) with skin type III. The skin specimens were frozen and stored at -70°C promptly after removal. Before analysis, the skin samples were thawed at room temperature and the epidermis, where most of the synthesis of vitamin D3 takes place, was separated from the dermis (15). Individual skin pieces (1 cm2) were exposed to simulated sunlight for the same period of time, after which the epidermis was immediately removed and analyzed for its combined vitamin D3 content (the combination of previtamin D3 and vitamin D3) as described previously (15). The vitamin D3 precursor 7-dehydrocholesterol and its photoproduct previtamin D3 were measured in triplicate by HPLC (15).

Statistical analysis
Individual comparisons between the 2 groups were performed with Student's t test. Changes across the 4 time points were compared between the 2 groups in the oral study by using a two-factor repeated-measures analysis of variance. Linear relations between BMI and different variables were computed by using Pearson correlation coefficients (16). Results were considered significant if P values were <0.05. All results are expressed as means ± SEMs.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 SUBJECTS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
In the UV-B irradiation study, basal concentrations of vitamin D3 were not significantly different between the obese and nonobese control groups (Figure 1Go). There was a significant increase in the circulating concentrations of vitamin D3 in both groups 24 h after irradiation. There was also a significant difference (P = 0.0042) between the response of each group, with the obese subjects showing an attenuated response to UV-B irradiation. When the results were recalculated as the difference between basal and postirradiation vitamin D3 concentrations, they were still significantly different [control subjects: 38.3 ± 5.5 nmol/L (15.3 ± 2.1 ng/mL); obese subjects: 17.4 ± 3.6 nmol/L (6.7 ± 1.4 ng/mL); P = 0.0029].



View larger version (11K):
[in this window]
[in a new window]
 
FIGURE 1. . Mean (±SEM) serum vitamin D3 (cholecalciferol) concentrations before ({blacksquare}) and 24 h after ({square}) whole-body irradiation (27 mJ/cm2) with ultraviolet B radiation. The response of the obese subjects was attenuated when compared with that of the control group. There was a significant time-by-group interaction, P = 0.003. *Significantly different from before values (P < 0.05).

 
In the oral vitamin D2 loading test, basal serum concentrations of vitamin D2 were not significantly different between groups [control subjects: 5.3 ± 0.2 nmol/L (2.1 ± 0.6 ng/mL); obese subjects: 3.5 ± 1.5 nmol/L (1.4 ± 0.6 ng/mL); Figure 2Go]. Additionally, there were no significant differences in basal vitamin D3 concentrations [control subjects: 2.5 + 1.8 nmol/L (1.0 ± 0.7 ng/mL); obese subjects: 2.3 ± 2.3 nmol/L (0.9 ± 0.9 ng/mL)] or 1,25(OH)2D [control subjects: 104.6 ± 14.6 pmol/L (43.5 ± 5.8 pg/mL); obese subjects: 96.6 ± 6.7 pmol/L (40.2 ± 2.8 pg/mL)]. However, 25(OH)D concentrations were significantly lower [50.0 ± 7.5 nmol/L (20.0 ± 3.4 ng/mL) compared with 84.8 ± 10.3 nmol/L (33.9 ± 4.1 ng/mL); P = 0.017] and parathyroid hormone concentrations were significantly higher (0.80 ± 0.05 compared with 0.63 ± 0.04 pmol/L; P = 0.0291) in the obese subjects than in the control subjects. After the oral intake of vitamin D2, there was a marked increase in serum vitamin D2 concentrations, with a significant effect of both time (P = 0.00001) and group (P = 0.0186); there was no significant time-by-group interaction (Figure 2Go). Peak vitamin D2 concentrations did not differ significantly between the 2 groups [control subjects: 233.3 nmol/L (92.4 ng/mL); obese subjects: 181.6 nmol/L (71.9 ng/mL); P = 0.0603] nor did the difference between peak and basal vitamin D2 concentrations [control subjects: 230.6 nmol/L (91.3 ng/mL); obese subjects: 185.4 nmol/L (73.4 ng/mL)]. There was a significant difference in the kinetics of the 25(OH)D response between groups (P = 0.0481, ANOVA time-by-group interaction; Figure 3Go). Follow-up analysis showed that the effect of time was significant (P = 0.0041), whereas the effect of group was not. Testing for changes in vitamin D2 and 1,25(OH)2D concentrations throughout the oral vitamin D2 loading test showed that the group-by-time interaction, the time effect, and the group effect were not significant.



View larger version (13K):
[in this window]
[in a new window]
 
FIGURE 2. . Mean (±SEM) serum vitamin D2 (ergocalciferol) concentrations in the control (•) and obese ({circ}) groups 0–25 h after oral intake of vitamin D2 (50000 IU, 1.25 mg). Vitamin D2 rose rapidly until {approx}10 h after intake and then declined slightly thereafter. *Significant time and group effects by ANOVA (P < 0.05) but no significant time-by-group interaction. The difference in peak concentrations between the obese and nonobese control subjects was not significant.

 


View larger version (12K):
[in this window]
[in a new window]
 
FIGURE 3. . Mean (±SEM) serum 25-hydroxyvitamin D [25(OH)D] concentrations in the control (•) and obese ({circ}) groups 0–24 h after oral intake of vitamin D2 (ergocalciferol; 50000 IU, 1.25 mg). The slight increase in the obese group was not significant. *Significant time-by-group interaction, P < 0.05 (ANOVA).

 
The effect of BMI on blood concentrations of vitamin D and its metabolites were evaluated by determining the correlation coefficients for the relations. Correlations between BMI and basal vitamin D2, basal 25(OH)D, 25(OH)D, basal 1,25(OH)2D, peak 25(OH)D, and basal vitamin D were not significant. Conversely, there were 2 correlations that were highly significant: those between BMI and peak serum vitamin D2 concentrations after the oral vitamin D2 load (Figure 4Go) and between BMI and serum vitamin D3 concentrations after UV-B irradiation (Figure 5Go).



View larger version (12K):
[in this window]
[in a new window]
 
FIGURE 4. . Correlation between BMI and peak serum vitamin D2 (ergocalciferol) concentrations in the control (•) and obese ({square}) groups after oral intake of vitamin D2 (50000 IU, 1.25 mg). The correlation coefficient (r = -0.56) was highly significant (P = 0.007).

 


View larger version (13K):
[in this window]
[in a new window]
 
FIGURE 5. . Correlation between BMI and peak serum vitamin D3 (cholecalciferol) concentrations after whole-body irradiation (27 mJ/cm2) with ultraviolet B radiation in control (•) and obese ({square}) subjects. The correlation coefficient (r = 0.55) was highly significant (P = 0.003).

 
The percentage conversion of provitamin D3 (7-dehydrocholesterol) to vitamin D3 in skin was not significantly different between the young obese and young nonobese subjects (9.4 ± 1.9% compared with 9.6 ± 1.1%) nor between the older obese and older nonobese subjects (7.6 ± 0.5% compared with 7.3 ± 0.5%).


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 SUBJECTS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
The present study of the synthesis and processing of vitamin D confirmed that obese patients have lower basal 25(OH)D and higher serum parathyroid hormone concentrations than do nonobese persons (15). To determine why obese individuals are prone to vitamin D deficiency, we conducted a series of studies to determine their capability to handle vitamin D originating from either the oral route or from the skin. Because vitamin D is fat soluble and is readily stored in adipose tissue, it could be sequestered in the larger body pool of fat of obese individuals. We observed that blood vitamin D3 concentrations increased in both the obese and nonobese subjects after exposure to an identical amount of UV-B irradiation. Moreover, the obese subjects had a larger body surface area of exposure and therefore would be expected to produce more vitamin D3, resulting in higher blood vitamin D3 concentrations, than would the nonobese control subjects. However, the increase in blood vitamin D3 concentrations was 57% less in the obese than in the nonobese subjects 24 h after the exposure. The content of the vitamin D3 precursor 7-dehydrocholesterol in the skin was not significantly different between obese and nonobese subjects, consistent with previous observations (17, 18). Furthermore, the percentage conversion to previtamin D3 and vitamin D3 was similar in both groups. Thus, obesity did not affect the capacity of the skin to produce vitamin D3, but may have altered the release of vitamin D3 from the skin into the circulation.

It is possible that the subcutaneous fat, which is known to store vitamin D3, sequestered more of the cutaneous synthesized vitamin D3 in the obese than in the nonobese subjects because there was more fat available for this process. To determine whether the same phenomenon occurred when vitamin D was ingested orally, obese and nonobese subjects were challenged with an oral dose of 50000 IU vitamin D2. There was no relation between basal vitamin D2 concentrations and 25(OH)D. Peak blood concentrations of vitamin D2 were not significantly different between the obese and nonobese subjects. However, BMI was inversely correlated with peak blood vitamin D2 concentrations. Thus, the orally supplied vitamin D2 was more bioavailable, probably because after absorption into the lymphatic system and transfer into the bloodstream, it is also sequestered in the large pool of body fat.

Because humans obtain most of their vitamin D requirement from casual exposure to sunlight, the >50% decreased bioavailability of cutaneously synthesized vitamin D3 in the obese subjects could account for the consistent observation by us and others that obesity is associated with vitamin D deficiency. Oral vitamin D should be able to correct the vitamin D deficiency associated with obesity, but larger than usual doses may be required for very obese patients.


    ACKNOWLEDGMENTS
 
We thank B Hollis (Medical University of South Carolina, Charleston) for measuring the parathyroid hormone concentrations.


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 SUBJECTS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Bell NH, Epstein S, Greene A, Shary J, Oexmann MJ, Shaw S. Evidence for alteration of the vitamin D-endocrine system in obese subjects. J Clin Invest 1985;76:370–3.
  2. Liel Y, Ulmer E, Shary J, Hollis BW, Bell NH. Low circulating vitamin D in obesity. Calcif Tissue Int 1988;43:199–201.[Medline]
  3. Compston JE, Vedi S, Ledger JE, Webb A, Gazet JC, Pilkington TRE. Vitamin D status and bone histomorphometry in gross obesity. Am J Clin Nutr 1981;34:2359–63.[Abstract/Free Full Text]
  4. Hey H, Stockholm KH, Lund BJ, Sorensen OH. Vitamin D deficiency in obese patients and changes in circulating vitamin D metabolites following jejunoileal bypass. Int J Obes 1982;6:473–9.[Medline]
  5. Hyldstrup L, Andersen T, McNair P, Breum L, Transbol I. Bone metabolism in obesity: changes related to severe overweight and dietary weight reduction. Acta Endocrinol 1993;129:393–8.
  6. Bell NH, Epstein S, Shary J, Greene V, Oexmann MJ, Shaw S. Evidence of a probable role for 25-hydroxyvitamin D in the regulation of human calcium metabolism. J Bone Miner Res 1988;3:489–95.[Medline]
  7. Andersen T, McNair P, Fogh-Andersen H, Nielsen TT, Hyldstrup L, Transbol I. Increased parathyroid hormone as a consequence of changed complex binding of plasma calcium in morbid obesity. Metabolism 1985;35:147–51.
  8. Matsuoka LY, Wortsman J, Haddad JG, Kolm P, Hollis BW. Racial pigmentation and the cutaneous synthesis of vitamin D. Arch Dermatol 1991;127:536–8.[Abstract/Free Full Text]
  9. Matsuoka LY, Ide L, Wortsman J. MacLaughlin JA, Holick MF. Sunscreens suppress cutaneous vitamin D3 synthesis. J Clin Endocrinol Metab 1987;64:1165–8.[Abstract/Free Full Text]
  10. Avioli LV, Lee SW, McDonald JE, Lund J, DeLuca HF. Metabolism of vitamin D3–3H in human subjects: distribution in blood, bile, feces and urine. J Clin Invest 1967;46:983–92.
  11. Lo CW, Paris PW, Clemens TL, Nolan J, Holick MF. Vitamin D absorption in healthy subjects and in patients with intestinal malabsorption syndromes. Am J Clin Nutr 1985;42:644–9.[Abstract/Free Full Text]
  12. Chen TC, Turner AK, Holick MF. A method for the determination of the circulating concentration of vitamin D. J Nutr Biochem 1990; 1:272–6.
  13. Chen TC, Turner AK, Holick MF. Methods for the determination of the circulating concentration of 25-dihydoxyvitamin D. J Nutr Biochem 1990;1:315–9.[Medline]
  14. Chen TC, Turner AK, Holick MF. A method for the determination of the circulating concentration of 1,25-dihydroxyvitamin D. J Nutr Biochem 1990;1:320–7.
  15. Holick MF, MacLaughlin JA, Clark MB, et al. Photosynthesis of previtamin D3 in human skin and the physiologic consequences. Science 1980;210:203–5.[Abstract/Free Full Text]
  16. Kirk RE, ed. Experimental design: procedures for the behavioral sciences. 2nd ed. Monterey, CA: Brooks/Cole Publishing Co, 1982.
  17. MacLaughlin J, Holick MF. Aging decreases the capacity of human skin to produce vitamin D3. J Clin Invest 1985;76:1536–8.
  18. Need AG, Morris HA, Horowitz M, Nordin BEC. Effects of skin thickness, age, body fat, and sunlight on serum 25-hydroxyvitamin D. Am J Clin Nutr 1993;58:882–5.[Abstract/Free Full Text]
Received for publication August 31, 1999. Accepted for publication January 19, 2000.




This article has been cited by other articles:


Home page
NeurologyHome page
K. L. Munger, T. Chitnis, and A. Ascherio
Body size and risk of MS in two cohorts of US women
Neurology, November 10, 2009; 73(19): 1543 - 1550.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
D. Santini, S. Galluzzo, B. Vincenzi, A. Zoccoli, E. Ferraro, C. Lippi, V. Altomare, G. Tonini, and F. Bertoldo
Longitudinal evaluation of vitamin D plasma levels during anthracycline- and docetaxel-based adjuvant chemotherapy in early-stage breast cancer patients
Ann. Onc., November 5, 2009; (2009) mdp497v1.
[Full Text] [PDF]


Home page
Eur J EndocrinolHome page
E Wehr, S Pilz, N Schweighofer, A Giuliani, D Kopera, T R Pieber, and B Obermayer-Pietsch
Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome
Eur. J. Endocrinol., October 1, 2009; 161(4): 575 - 582.
[Abstract] [Full Text] [PDF]


Home page
AMERICAN JOURNAL OF LIFESTYLE MEDICINEHome page
J. L. Lapp
Vitamin D: Bone Health and Beyond
American Journal of Lifestyle Medicine, September 1, 2009; 3(5): 386 - 393.
[Abstract] [PDF]


Home page
Am. J. Clin. Nutr.Home page
C. M Lenders, H. A Feldman, E. Von Scheven, A. Merewood, C. Sweeney, D. M Wilson, P. D. Lee, S. H Abrams, S. E Gitelman, M. S Wertz, et al.
Relation of body fat indexes to vitamin D status and deficiency among obese adolescents
Am. J. Clinical Nutrition, September 1, 2009; 90(3): 459 - 467.
[Abstract] [Full Text] [PDF]


Home page
J Geriatr Psychiatry NeurolHome page
D. J. Llewellyn, K. M. Langa, and I. A. Lang
Serum 25-Hydroxyvitamin D Concentration and Cognitive Impairment
J Geriatr Psychiatry Neurol, September 1, 2009; 22(3): 188 - 195.
[Abstract] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
K. A. Young, C. D. Engelman, C. D. Langefeld, K. G. Hairston, S. M. Haffner, M. Bryer-Ash, and J. M. Norris
Association of Plasma Vitamin D Levels with Adiposity in Hispanic and African Americans
J. Clin. Endocrinol. Metab., September 1, 2009; 94(9): 3306 - 3313.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Ashraf, J. Alvarez, K. Saenz, B. Gower, K. McCormick, and F. Franklin
Threshold for Effects of Vitamin D Deficiency on Glucose Metabolism in Obese Female African-American Adolescents
J. Clin. Endocrinol. Metab., September 1, 2009; 94(9): 3200 - 3206.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. Jenab, J. McKay, H. B. Bueno-de-Mesquita, F. J.B. van Duijnhoven, P. Ferrari, N. Slimani, E. H.J.M. Jansen, T. Pischon, S. Rinaldi, A. Tjonneland, et al.
Vitamin D Receptor and Calcium Sensing Receptor Polymorphisms and the Risk of Colorectal Cancer in European Populations
Cancer Epidemiol. Biomarkers Prev., September 1, 2009; 18(9): 2485 - 2491.
[Abstract] [Full Text] [PDF]


Home page
Anticancer ResHome page
B. NURNBERG, S. GRABER, B. GARTNER, J. GEISEL, C. PFOHLER, D. SCHADENDORF, W. TILGEN, and J. REICHRATH
Reduced Serum 25-Hydroxyvitamin D Levels in Stage IV Melanoma Patients
Anticancer Res, September 1, 2009; 29(9): 3669 - 3674.
[Abstract] [Full Text] [PDF]


Home page
Anticancer ResHome page
Z. LAGUNOVA, A. C. POROJNICU, F. LINDBERG, S. HEXEBERG, and J. MOAN
The Dependency of Vitamin D Status on Body Mass Index, Gender, Age and Season
Anticancer Res, September 1, 2009; 29(9): 3713 - 3720.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
J. Kumar, P. Muntner, F. J. Kaskel, S. M. Hailpern, and M. L. Melamed
Prevalence and Associations of 25-Hydroxyvitamin D Deficiency in US Children: NHANES 2001-2004
Pediatrics, September 1, 2009; 124(3): e362 - e370.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
I. H. de Boer, B. Kestenbaum, A. B. Shoben, E. D. Michos, M. J. Sarnak, and D. S. Siscovick
25-Hydroxyvitamin D Levels Inversely Associate with Risk for Developing Coronary Artery Calcification
J. Am. Soc. Nephrol., August 1, 2009; 20(8): 1805 - 1812.
[Abstract] [Full Text] [PDF]


Home page
Diabetes and Vascular Disease ResearchHome page
C. Luo, J. Wong, M. Brown, M. Hooper, L. Molyneaux, and D.K. Yue
Hypovitaminosis D in Chinese type 2 diabetes: Lack of impact on clinical metabolic status and biomarkers of cellular inflammation
Diabetes and Vascular Disease Research, July 1, 2009; 6(3): 194 - 199.
[Abstract] [PDF]


Home page
Diabetes CareHome page
L. Lu, Z. Yu, A. Pan, F. B. Hu, O. H. Franco, H. Li, X. Li, X. Yang, Y. Chen, and X. Lin
Plasma 25-Hydroxyvitamin D Concentration and Metabolic Syndrome Among Middle-Aged and Elderly Chinese Individuals
Diabetes Care, July 1, 2009; 32(7): 1278 - 1283.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
J. Chan, K. Jaceldo-Siegl, and G. E Fraser
Serum 25-hydroxyvitamin D status of vegetarians, partial vegetarians, and nonvegetarians: the Adventist Health Study-2
Am. J. Clinical Nutrition, May 1, 2009; 89(5): 1686S - 1692S.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
S. M Smith, K. K Gardner, J. Locke, and S. R Zwart
Vitamin D supplementation during Antarctic winter
Am. J. Clinical Nutrition, April 1, 2009; 89(4): 1092 - 1098.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
A. A. Ginde, M. C. Liu, and C. A. Camargo Jr
Demographic Differences and Trends of Vitamin D Insufficiency in the US Population, 1988-2004
Arch Intern Med, March 23, 2009; 169(6): 626 - 632.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
S. Saintonge, H. Bang, and L. M. Gerber
Implications of a New Definition of Vitamin D Deficiency in a Multiracial US Adolescent Population: The National Health and Nutrition Examination Survey III
Pediatrics, March 1, 2009; 123(3): 797 - 803.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
M. L. Nelson, J. M. Blum, B. W. Hollis, C. Rosen, and S. S. Sullivan
Supplements of 20 {micro}g/d Cholecalciferol Optimized Serum 25-Hydroxyvitamin D Concentrations in 80% of Premenopausal Women in Winter
J. Nutr., March 1, 2009; 139(3): 540 - 546.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. Eastell, A. Arnold, M. L. Brandi, E. M. Brown, P. D'Amour, D. A. Hanley, D. S. Rao, M. R. Rubin, D. Goltzman, S. J. Silverberg, et al.
Diagnosis of Asymptomatic Primary Hyperparathyroidism: Proceedings of the Third International Workshop
J. Clin. Endocrinol. Metab., February 1, 2009; 94(2): 340 - 350.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M. Sinotte, C. Diorio, S. Berube, M. Pollak, and J. Brisson
Genetic polymorphisms of the vitamin D binding protein and plasma concentrations of 25-hydroxyvitamin D in premenopausal women
Am. J. Clinical Nutrition, February 1, 2009; 89(2): 634 - 640.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. Kremer, P. P. Campbell, T. Reinhardt, and V. Gilsanz
Vitamin D Status and Its Relationship to Body Fat, Final Height, and Peak Bone Mass in Young Women
J. Clin. Endocrinol. Metab., January 1, 2009; 94(1): 67 - 73.
[Abstract] [Full Text] [PDF]


Home page
Am Soc Clin Oncol Ed BookHome page
C. J. Fabian
If Vitamin D Prevents Breast Cancer, How Does It Do It, and How Much Does It Take?
ASCO Educational Book, January 1, 2009; 2009(1): 71 - 74.
[Abstract] [Full Text] [PDF]


Home page
Am Soc Clin Oncol Ed BookHome page
O. C. Freedman and P. J. Goodwin
The Role of Vitamin D in Breast Cancer Recurrence
ASCO Educational Book, January 1, 2009; 2009(1): 79 - 83.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. H. Lee, J. H. O'Keefe, D. Bell, D. D. Hensrud, and M. F. Holick
Vitamin D Deficiency: An Important, Common, and Easily Treatable Cardiovascular Risk Factor?
J. Am. Coll. Cardiol., December 9, 2008; 52(24): 1949 - 1956.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. Y. Wei, C. F. Garland, E. D. Gorham, S. B. Mohr, and E. Giovannucci
Vitamin D and Prevention of Colorectal Adenoma: A Meta-analysis
Cancer Epidemiol. Biomarkers Prev., November 1, 2008; 17(11): 2958 - 2969.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M. Bortolotti, S. Rudelle, P. Schneiter, H. Vidal, E. Loizon, L. Tappy, and K. J Acheson
Dairy calcium supplementation in overweight or obese persons: its effect on markers of fat metabolism
Am. J. Clinical Nutrition, October 1, 2008; 88(4): 877 - 885.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D.-H. Manicourt and J.-P. Devogelaer
Urban Tropospheric Ozone Increases the Prevalence of Vitamin D Deficiency among Belgian Postmenopausal Women with Outdoor Activities during Summer
J. Clin. Endocrinol. Metab., October 1, 2008; 93(10): 3893 - 3899.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. Fleischer, E. M. Stein, M. Bessler, M. D. Badia, N. Restuccia, L. Olivero-Rivera, D. J. McMahon, and S. J. Silverberg
The Decline in Hip Bone Density after Gastric Bypass Surgery Is Associated with Extent of Weight Loss
J. Clin. Endocrinol. Metab., October 1, 2008; 93(10): 3735 - 3740.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
H. M. Ochs-Balcom, M. S. Cicek, C. L. Thompson, T. C. Tucker, R. C. Elston, S. J.Plummer, G. Casey, and L. Li
Association of vitamin D receptor gene variants, adiposity and colon cancer
Carcinogenesis, September 1, 2008; 29(9): 1788 - 1793.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
J. A. Cauley, A. Z. LaCroix, L. Wu, M. Horwitz, M. E. Danielson, D. C. Bauer, J. S. Lee, R. D. Jackson, J. A. Robbins, C. Wu, et al.
Serum 25-Hydroxyvitamin D Concentrations and Risk for Hip Fractures
Ann Intern Med, August 19, 2008; 149(4): 242 - 250.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
M. L. Melamed, E. D. Michos, W. Post, and B. Astor
25-Hydroxyvitamin D Levels and the Risk of Mortality in the General Population
Arch Intern Med, August 11, 2008; 168(15): 1629 - 1637.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
E. A Yetley
Assessing the vitamin D status of the US population
Am. J. Clinical Nutrition, August 1, 2008; 88(2): 558S - 564S.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
M. Misra, D. Pacaud, A. Petryk, P. F. Collett-Solberg, M. Kappy, and on behalf of the Drug and Therapeutics Committee o
Vitamin D Deficiency in Children and Its Management: Review of Current Knowledge and Recommendations
Pediatrics, August 1, 2008; 122(2): 398 - 417.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
S. Mark, K. Gray-Donald, E. E. Delvin, J. O'Loughlin, G. Paradis, E. Levy, and M. Lambert
Low Vitamin D Status in a Representative Sample of Youth From Quebec, Canada
Clin. Chem., August 1, 2008; 54(8): 1283 - 1289.
[Abstract] [Full Text] [PDF]


Home page
Arch Pediatr Adolesc MedHome page
C. M. Gordon, H. A. Feldman, L. Sinclair, A. L. Williams, P. K. Kleinman, J. Perez-Rossello, and J. E. Cox
Prevalence of Vitamin D Deficiency Among Healthy Infants and Toddlers
Arch Pediatr Adolesc Med, June 1, 2008; 162(6): 505 - 512.
[Abstract] [Full Text] [PDF]


Home page
Cleveland Clinic Journal of MedicineHome page
S. E. WILLIAMS, K. COOPER, B. RICHMOND, and P. SCHAUER
Perioperative management of bariatric surgery patients: Focus on metabolic bone disease
Cleveland Clinic Journal of Medicine, May 1, 2008; 75(5): 333 - 349.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
W. J. G. Hoogendijk, P. Lips, M. G. Dik, D. J. H. Deeg, A. T. F. Beekman, and B. W. J. H. Penninx
Depression Is Associated With Decreased 25-Hydroxyvitamin D and Increased Parathyroid Hormone Levels in Older Adults
Arch Gen Psychiatry, May 1, 2008; 65(5): 508 - 512.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M. F Holick and T. C Chen
Vitamin D deficiency: a worldwide problem with health consequences
Am. J. Clinical Nutrition, April 1, 2008; 87(4): 1080S - 1086S.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
M. Blum, G. E. Dallal, and B. Dawson-Hughes
Body Size and Serum 25 Hydroxy Vitamin D Response to Oral Supplements in Healthy Older Adults
J. Am. Coll. Nutr., April 1, 2008; 27(2): 274 - 279.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
J. C. McCann and B. N. Ames
Is there convincing biological or behavioral evidence linking vitamin D deficiency to brain dysfunction?
FASEB J, April 1, 2008; 22(4): 982 - 1001.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
E. T Jacobs, D. S Alberts, J. A Foote, S. B Green, B. W Hollis, Z. Yu, and M. E. Martinez
Vitamin D insufficiency in southern Arizona
Am. J. Clinical Nutrition, March 1, 2008; 87(3): 608 - 613.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
E. T Aasheim, D. Hofso, J. Hjelmesaeth, K. I Birkeland, and T. Bohmer
Vitamin status in morbidly obese patients: a cross-sectional study
Am. J. Clinical Nutrition, February 1, 2008; 87(2): 362 - 369.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
E. Hypponen, B. J. Boucher, D. J. Berry, and C. Power
25-Hydroxyvitamin D, IGF-1, and Metabolic Syndrome at 45 Years of Age: A Cross-Sectional Study in the 1958 British Birth Cohort
Diabetes, February 1, 2008; 57(2): 298 - 305.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Moan, A. C. Porojnicu, A. Dahlback, and R. B. Setlow
From the Cover: Addressing the health benefits and risks, involving vitamin D or skin cancer, of increased sun exposure
PNAS, January 15, 2008; 105(2): 668 - 673.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
A. H. Lichtenstein, H. Rasmussen, W. W. Yu, S. R. Epstein, and R. M. Russell
Modified MyPyramid for Older Adults
J. Nutr., January 1, 2008; 138(1): 5 - 11.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. Ahn, D. Albanes, U. Peters, A. Schatzkin, U. Lim, M. Freedman, N. Chatterjee, G. L. Andriole, M. F. Leitzmann, R. B. Hayes, et al.
Dairy Products, Calcium Intake, and Risk of Prostate Cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
Cancer Epidemiol. Biomarkers Prev., December 1, 2007; 16(12): 2623 - 2630.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
A. Burgaz, A. Akesson, A. Oster, K. Michaelsson, and A. Wolk
Associations of diet, supplement use, and ultraviolet B radiation exposure with vitamin D status in Swedish women during winter
Am. J. Clinical Nutrition, November 1, 2007; 86(5): 1399 - 1404.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
N. K Pollock, E. M Laing, C. A Baile, M. W Hamrick, D. B Hall, and R. D Lewis
Is adiposity advantageous for bone strength? A peripheral quantitative computed tomography study in late adolescent females
Am. J. Clinical Nutrition, November 1, 2007; 86(5): 1530 - 1538.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
L. M. Bodnar, J. M. Catov, J. M. Roberts, and H. N. Simhan
Prepregnancy Obesity Predicts Poor Vitamin D Status in Mothers and Their Neonates
J. Nutr., November 1, 2007; 137(11): 2437 - 2442.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M. J Bolland, A. B Grey, R. W Ames, B. H Mason, A. M Horne, G. D Gamble, and I. R Reid
The effects of seasonal variation of 25-hydroxyvitamin D and fat mass on a diagnosis of vitamin D sufficiency
Am. J. Clinical Nutrition, October 1, 2007; 86(4): 959 - 964.
[Abstract] [Full Text] [PDF]


Home page
Biol Res NursHome page
P. T. Alpert and U. Shaikh
The Effects of Vitamin D Deficiency and Insufficiency on the Endocrine and Paracrine Systems
Biol Res Nurs, October 1, 2007; 9(2): 117 - 129.
[Abstract] [PDF]


Home page
J Am Acad Orthop SurgHome page
P. A. Thomas
Racial and Ethnic Differences in Osteoporosis
J. Am. Acad. Ortho. Surg., September 1, 2007; 15(suppl_1): S26 - S30.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
C. P. Kovesdy, S. Ahmadzadeh, J. E. Anderson, and K. Kalantar-Zadeh
Obesity Is Associated with Secondary Hyperparathyroidism in Men with Moderate and Severe Chronic Kidney Disease
Clin. J. Am. Soc. Nephrol., September 1, 2007; 2(5): 1024 - 1029.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
T. Reinehr, G. de Sousa, U. Alexy, M Kersting, and W. Andler
Vitamin D status and parathyroid hormone in obese children before and after weight loss
Eur. J. Endocrinol., August 1, 2007; 157(2): 225 - 232.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. S. Harris and B. Dawson-Hughes
Reduced Sun Exposure Does Not Explain the Inverse Association of 25-Hydroxyvitamin D with Percent Body Fat in Older Adults
J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 3155 - 3157.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
D. Martins, M. Wolf, D. Pan, A. Zadshir, N. Tareen, R. Thadhani, A. Felsenfeld, B. Levine, R. Mehrotra, and K. Norris
Prevalence of Cardiovascular Risk Factors and the Serum Levels of 25-Hydroxyvitamin D in the United States: Data From the Third National Health and Nutrition Examination Survey
Arch Intern Med, June 11, 2007; 167(11): 1159 - 1165.
[Abstract] [Full Text] [PDF]


Home page
Nutr Clin PractHome page
L. Shinchuk and M. F. Holick
Vitamin D and Rehabilitation: Improving Functional Outcomes
Nutr Clin Pract, June 1, 2007; 22(3): 297 - 304.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. G. Pittas, J. Lau, F. B. Hu, and B. Dawson-Hughes
The Role of Vitamin D and Calcium in Type 2 Diabetes. A Systematic Review and Meta-Analysis
J. Clin. Endocrinol. Metab., June 1, 2007; 92(6): 2017 - 2029.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
R. M van Dam, M. B Snijder, J. M Dekker, C. D. Stehouwer, L. M Bouter, R. J Heine, and P. Lips
Potentially modifiable determinants of vitamin D status in an older population in the Netherlands: the Hoorn Study
Am. J. Clinical Nutrition, March 1, 2007; 85(3): 755 - 761.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
E. Hypponen and C. Power
Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors
Am. J. Clinical Nutrition, March 1, 2007; 85(3): 860 - 868.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
H. F. Saadi, E. Kazzam, B. A. Ghurbana, and M. G. Nicholls
Hypothesis: Correction of low vitamin D status among Arab women will prevent heart failure and improve cardiac function in established heart failure
Eur J Heart Fail, November 1, 2006; 8(7): 694 - 696.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
E. Hypponen and C. Power
Vitamin D Status and Glucose Homeostasis in the 1958 British Birth Cohort: The role of obesity
Diabetes Care, October 1, 2006; 29(10): 2244 - 2246.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
S. A. Shapses and C. S. Riedt
Bone, Body Weight, and Weight Reduction: What Are the Concerns?
J. Nutr., June 1, 2006; 136(6): 1453 - 1456.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
E. Giovannucci, Y. Liu, E. B. Rimm, B. W. Hollis, C. S. Fuchs, M. J. Stampfer, and W. C. Willett
Prospective study of predictors of vitamin d status and cancer incidence and mortality in men.
J Natl Cancer Inst, April 5, 2006; 98(7): 451 - 459.
[Abstract] [Full Text] [PDF]


Home page
Mayo Clin Proc.Home page
M. F. Holick
High Prevalence of Vitamin D Inadequacy and Implications for Health
Mayo Clin. Proc., March 1, 2006; 81(3): 353 - 373.
[Abstract] [Full Text] [PDF]


Home page
AJPHHome page
C. F. Garland, F. C. Garland, E. D. Gorham, M. Lipkin, H. Newmark, S. B. Mohr, and M. F. Holick
The Role of Vitamin D in Cancer Prevention
Am J Public Health, February 1, 2006; 96(2): 252 - 261.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
J. E. Rockell, T. J. Green, C. M. Skeaff, S. J. Whiting, R. W. Taylor, S. M. Williams, W. R. Parnell, R. Scragg, N. Wilson, D. Schaaf, et al.
Season and Ethnicity Are Determinants of Serum 25-Hydroxyvitamin D Concentrations in New Zealand Children Aged 5-14 y
J. Nutr., November 1, 2005; 135(11): 2602 - 2608.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
M. F. Holick
The Vitamin D Epidemic and its Health Consequences
J. Nutr., November 1, 2005; 135(11): 2739S - 2748S.
[Abstract] [Full Text] [PDF]


Home page
CLIN PEDIATRHome page
K. Rajakumar, J. D. Fernstrom, J. E. Janosky, and S. L. Greenspan
Vitamin D Insufficiency in Preadolescent African-American Children
Clinical Pediatrics, October 1, 2005; 44(8): 683 - 692.
[Abstract] [PDF]


Home page
Am. J. Clin. Nutr.Home page
W G. John, K. Noonan, N. Mannan, and B. J Boucher
Hypovitaminosis D is associated with reductions in serum apolipoprotein A-I but not with fasting lipids in British Bangladeshis
Am. J. Clinical Nutrition, September 1, 2005; 82(3): 517 - 522.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
D. Panidis, C. Balaris, D. Farmakiotis, D. Rousso, A. Kourtis, V. Balaris, I. Katsikis, V. Zournatzi, and E. Diamanti-Kandarakis
Serum Parathyroid Hormone Concentrations Are Increased in Women with Polycystic Ovary Syndrome
Clin. Chem., September 1, 2005; 51(9): 1691 - 1697.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. B. Snijder, R. M. van Dam, M. Visser, D. J. H. Deeg, J. M. Dekker, L. M. Bouter, J. C. Seidell, and P. Lips
Adiposity in Relation to Vitamin D Status and Parathyroid Hormone Levels: A Population-Based Study in Older Men and Women
J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 4119 - 4123.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. F. Holick, E. S. Siris, N. Binkley, M. K. Beard, A. Khan, J. T. Katzer, R. A. Petruschke, E. Chen, and A. E. de Papp
Prevalence of Vitamin D Inadequacy among Postmenopausal North American Women Receiving Osteoporosis Therapy
J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3215 - 3224.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
L. Fontana, J. L. Shew, J. O. Holloszy, and D. T. Villareal
Low Bone Mass in Subjects on a Long-term Raw Vegetarian Diet
Arch Intern Med, March 28, 2005; 165(6): 684 - 689.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. C. Looker
Body Fat and Vitamin D Status in Black Versus White Women
J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 635 - 640.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
S. J. Whiting and M. S. Calvo
Dietary Recommendations for Vitamin D: a Critical Need for Functional End Points to Establish an Estimated Average Requirement
J. Nutr., February 1, 2005; 135(2): 304 - 309.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
R Jorde, F Saleh, Y Figenschau, E Kamycheva, E Haug, and J Sundsfjord
Serum parathyroid hormone (PTH) levels in smokers and non-smokers. The fifth Tromso study
Eur. J. Endocrinol., January 1, 2005; 152(1): 39 - 45.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M. F Holick
Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease
Am. J. Clinical Nutrition, December 1, 2004; 80(6): 1678S - 1688S.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
D. M. Harris and V. L. W. Go
Vitamin D and Colon Carcinogenesis
J. Nutr., December 1, 2004; 134(12): 3463S - 3471S.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
V.-V. Valimaki, H. Alfthan, K. K. Ivaska, E. Loyttyniemi, K. Pettersson, U.-H. Stenman, and M. J. Valimaki
Serum Estradiol, Testosterone, and Sex Hormone-Binding Globulin as Regulators of Peak Bone Mass and Bone Turnover Rate in Young Finnish Men
J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 3785 - 3789.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M. Cifuentes, C. S Riedt, R. E Brolin, M P. Field, R. M Sherrell, and S. A Shapses
Weight loss and calcium intake influence calcium absorption in overweight postmenopausal women
Am. J. Clinical Nutrition, July 1, 2004; 80(1): 123 - 130.
[Abstract] [Full Text] [PDF]


Home page
Arch Pediatr Adolesc MedHome page
C. M. Gordon, K. C. DePeter, H. A. Feldman, E. Grace, and S. J. Emans
Prevalence of Vitamin D Deficiency Among Healthy Adolescents
Arch Pediatr Adolesc Med, June 1, 2004; 158(6): 531 - 537.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M. F Holick
Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis
Am. J. Clinical Nutrition, March 1, 2004; 79(3): 362 - 371.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. J. Parikh, M. Edelman, G. I. Uwaifo, R. J. Freedman, M. Semega-Janneh, J. Reynolds, and J. A. Yanovski
The Relationship between Obesity and Serum 1,25-Dihydroxy Vitamin D Concentrations in Healthy Adults
J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1196 - 1199.
[Abstract] [Full Text] [PDF]


Home page
Mayo Clin Proc.Home page
G. A. Plotnikoff and J. M. Quigley
Prevalence of Severe Hypovitaminosis D in Patients With Persistent, Nonspecific Musculoskeletal Pain
Mayo Clin. Proc., December 1, 2003; 78(12): 1463 - 1470.
[Abstract] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Arunabh, S. Pollack, J. Yeh, and J. F. Aloia
Body Fat Content and 25-Hydroxyvitamin D Levels in Healthy Women
J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 157 - 161.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
S. Nesby-O'Dell, K. S Scanlon, M. E Cogswell, C. Gillespie, B. W Hollis, A. C Looker, C. Allen, C. Doughertly, E. W Gunter, and B. A Bowman
Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988-1994
Am. J. Clinical Nutrition, July 1, 2002; 76(1): 187 - 192.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
A. Devine, S. G Wilson, I. M Dick, and R. L Prince
Effects of vitamin D metabolites on intestinal calcium absorption and bone turnover in elderly women
Am. J. Clinical Nutrition, February 1, 2002; 75(2): 283 - 288.
[Abstract] [Full Text]


Home page
Endocr. Rev.Home page
A. Slominski and J. Wortsman
Neuroendocrinology of the Skin
Endocr. Rev., October 1, 2000; 21(5): 457 - 487.
[Abstract] [Full Text]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow An erratum has been published
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wortsman, J.
Right arrow Articles by Holick, M. F
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wortsman, J.
Right arrow Articles by Holick, M. F
Agricola
Right arrow Articles by Wortsman, J.
Right arrow Articles by Holick, M. F


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS